Author:
Poudel Sujan,Quinonez Jonathan,Choudhari Jinal,Au Zachary T,Paesani Sylvia,Thiess Armond K,Ruxmohan Samir,Hosameddin Mobashir,Ferrer Gerardo F,Michel Jack
Reference34 articles.
1. Medical reasons for marijuana use, forms of use, and patient perception of physician attitudes among the US population;Azcarate PM;J Gen Intern Med,2020
2. Medicinal properties of cannabinoids, terpenes, and flavonoids in cannabis, and benefits in migraine, headache, and pain: an update on current evidence and cannabis science;Baron EP;Headache,2018
3. Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells;Giudice ED;J Leukoc Biol,2007
4. Cannabis and neuropsychiatric disorders: an updated review;Chayasirisobhon S;Acta Neurol Taiwan,2019
5. Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?;Russo EB;Neuro Endocrinol Lett,2008
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献